Dopamine Receptor
Dopamine Receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). The neurotransmitter dopamine is the primary endogenous ligand for dopamine receptors. Dopamine receptors are implicated in many neurological processes, including motivation, pleasure, cognition, memory, learning, and fine motor control, as well as modulation of neuroendocrine signaling. Abnormal dopamine receptor signaling and dopaminergic nerve function is implicated in several neuropsychiatric disorders. Thus, dopamine receptors are common neurologic drug targets; antipsychotics are often dopamine receptor antagonists while psychostimulants are typically indirect agonists of dopamine receptors. There are at least five subtypes of dopamine receptors, D1, D2, D3, D4, and D5. The D1 and D5 receptors are members of the D1-like family of dopamine receptors, whereas the D2, D3 and D4receptors are members of the D2-like family.
Dopamine Receptor Isoform Specific Products
All Product Categories
-
Dopamine Receptor Inhibitors
(144)
View all products
-
Dopamine Receptor Agonists
(257)
View all products
-
Dopamine Receptor Antagonists
(446)
View all products
-
Dopamine Receptor Activators
(20)
View all products
-
Dopamine Receptor Modulators
(46)
View all products
-
Dopamine Receptor Chemical
(1)
View all products
-
Dopamine Receptor MDM2 Inhibitor
(1)
View all products
-
Dopamine Receptor Controls
(7)
View all products
-
Dopamine Receptor Ligands
(17)
View all products
-
Dopamine Receptor Related Products (1078)
Related Products (1078)
-
Antibodies (7)
-
Related Compound Screening Libraries (1)
-
Dopamine Receptor Isoform Comparison
-
Ziprasidone (Standard)
0 ImagesSynonyms: CP-88059 (Standard)Ziprasidone (Standard) is the analytical standard of Ziprasidone. This product is intended for research and analytical applications. Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM).
-
Fananserin (Standard)
0 ImagesCat. No.: HY-103104RCAS No.: 127625-29-0Synonyms: RP 62203 (Standard)Fananserin (Standard) is the analytical standard of Fananserin (HY-103104). This product is intended for research and analytical applications. Fananserin (RP 62203) is an orally bioavailable, potent and selective 5-hydroxytryptamine2 (5-HT2) receptor antagonist, with a Ki of 0.37 nM for the rat 5-HT2A receptor. Fananserin also is a selective dopamine D4 receptor antagonist, with a Ki of 2.93 nM for the human dopamine D4 receptor.
-
(±) Anabasine (Standard)
0 Images(±) Anabasine (Standard) is the analytical standard of (±) Anabasine (HY-W052144). This product is intended for research and analytical applications. (±) Anabasine is the racemic form of Anabasine (HY-B1532). (±) Anabasine stimulates the release of [3H]-Dopamine from mouse striatal synaptosomes. (±) Anabasine inhibits the high-affinity binding of [3H]-S-(-)-Nicotine to the striatal membrane. Anabasine is an agonist of α7nAChR and possesses anti-inflammatory and insecticidal activities.
-
S3608
0 ImagesCat. No.: HY-123440CAS No.: 57359-17-8S3608 is an atypical dopamine agonist. S3608 dose dependently increase locomotor activity (LA) in rats.
-
ST-836
0 ImagesCat. No.: HY-15238CAS No.: 1148156-63-1ST-836 is a dopamine receptor ligand; Antiparkinsonian agent.
-
Sonepiprazole mesylate
0 ImagesCat. No.: HY-123676CAS No.: 170858-34-1Synonyms: PNU-101387G mesylate; U-101387G mesylateSonepiprazole mesylate is a selective D4 dopamine antagonist with Kis of 3.6, 10.1, 5147, and 7430 nM for rD4-Dopamine, hD4.2-Dopamine, rD2-Dopamine, and Histamine-H1 receptors, respectively.
-
A31472
0 ImagesCat. No.: HY-119076CAS No.: 69319-52-4A31472 is a dopamine D-2 receptors antagonist that is promising for research of antipsychotic agents.
-
Abaperidone
0 ImagesCat. No.: HY-101619CAS No.: 183849-43-6Abaperidone is a potent antagonist of 5-HT2A receptor and dopamine D2 receptor with IC50s of 6.2 and 17 nM.
-
Org-10490
0 ImagesCat. No.: HY-U00077CAS No.: 83507-02-2Org-10490 is an antagonist of dopamine D1 receptor and dopamine D2 receptor, used for the treatment for psychiatric disease.
-
NRA-0160
0 ImagesCat. No.: HY-101641CAS No.: 204718-47-8NRA-0160 is a selective dopamine D4 receptor antagonist, with a Ki value of 0.48 nM and with negligible affinity for dopamine D2 receptor (Ki: >10000 nM), D3 receptor (Ki: 39 nM), rat 5-HT2A receptor (Ki: 180 nM) and rat α1 adrenoceptor (Ki: 237 nM).
-
ABT-670
0 ImagesCat. No.: HY-19483CAS No.: 630119-43-6ABT-670 is a selective, oral bioavailable agonist of dopamine D4 receptor, with EC50 of 89 nM, 160 nM, and 93 nM for human D4, ferret D4, and rat D4, respectively.
-
Dehydrosertindole
0 ImagesCat. No.: HY-118477CAS No.: 173294-84-3Dehydrosertindole is a blood-brain barrier-permeable, orally active inhibitor of the dopamine D2 receptor. Dehydrosertindole occupies striatal dopamine D2 receptors to mediate receptor regulation. Dehydrosertindole is the active metabolite of Sertindole (HY-14543), which distributes rapidly in guinea pig myocardium and inhibits conditioned avoidance responses in rats. Dehydrosertindole can be used in research related to schizophrenia.
-
Lumateperone-d4
0 ImagesCat. No.: HY-17637S2CAS No.: 2102683-55-4Synonyms: ITI-007-d4Lumateperone-d4 (ITI-007-d4) is deuterium labeled Lumateperone. Lumateperone (ITI-007) is an orally active 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone has anticancer activity and can also be used for the study of schizophrenia and bipolar depression.
-
Lensiprazine
0 ImagesCat. No.: HY-14793CAS No.: 327026-93-7Lensiprazine is a potent dopamine D2 receptor (D2R) antagonist that acts as a serotonin reuptake inhibitor. Lensiprazine can be used to study bipolar disorder and schizophrenia.
-
NMI 8739 (Standard)
0 ImagesCat. No.: HY-101540RCAS No.: 129024-87-9
-
Haloperidol decanoate (Standard)
0 ImagesCat. No.: HY-107969RCAS No.: 74050-97-8Haloperidol decanoate (Standard) is the analytical standard of Haloperidol decanoate. This product is intended for research and analytical applications. Haloperidol decanoate is a depot preparation of haloperidol, a commonly used butyrophenone derivative with antipsychotic activity. Haloperidol decanoate can increase the striatal D2 receptor in rat. Haloperidol decanoate can improve conditions of psychoses (mainly schizophrenia). Haloperidol decanoate can lead to increased accumulation of the dopamine metabolites homo-vanillic acid. Haloperidol decanoate can reduce intestinal transport, increase gastric emptying and reduce acid output in rat model.
-
Fluphenazine-d6 hydrochloride
0 ImagesCat. No.: HY-119980BSFluphenazine-d6 (hydrochloride) is deuterium labeled Fluphenazine (hydrochloride). Fluphenazine hydrochloride is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine hydrochloride blocks neuronal voltage-gated sodium channels. Fluphenazine hydrochloride acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine hydrochloride can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine hydrochloride can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2.
-
Brilaroxazine (Standard)
0 ImagesSynonyms: RP5063 (Standard)Brilaroxazine (Standard) is the analytical standard of Brilaroxazine. This product is intended for research and analytical applications. Brilaroxazine (RP5603) is a potent and orally active multimodal dopamine (DA)/serotonin (5-HT) modulator. Brilaroxazine is a partial agonist of dopamine (DA) D2, D3, and D4 receptors, 5-HT1A (Ki=1.5 nM) and 5-HT2A (Ki=2.5 nM), and has antagonist activity at 5-HT2B (Ki=0.19 nM), and 5-HT7 (Ki=2.7 nM) receptors. Brilaroxazine is an atypical antipsychotic agent, and has the potential to improve cognitive impairments in neuropsychiatric and neurological diseases in vivo.
